SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-221209
Filing Date
2022-08-15
Accepted
2022-08-15 16:15:07
Documents
14
Period of Report
2022-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d256519d8k.htm   iXBRL 8-K 25264
2 EX-99.1 d256519dex991.htm EX-99.1 43664
6 GRAPHIC g256519g08a65.jpg GRAPHIC 13373
  Complete submission text file 0001193125-22-221209.txt   220367

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aclx-20220815.xsd EX-101.SCH 2834
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20220815_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20220815_pre.xml EX-101.PRE 11693
8 EXTRACTED XBRL INSTANCE DOCUMENT d256519d8k_htm.xml XML 3467
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 221165810
SIC: 2836 Biological Products, (No Diagnostic Substances)